New ETF Book by Larry Connors - Click here to read more
Doubleday joins DexCom from Johnson & Johnson, where he spent over 21 years at several operating companies, including the past 13 years working in the diabetes space for both LifeScan and Animas. Doubleday will report to Terry Gregg, DexCom's President and Chief Executive Officer.
"We are delighted that Rick has agreed to lead our sales activities. Rick brings to DexCom not only a proven track record of sales leadership, but many professional working relationships in the diabetes community, which is consistent with my core belief that a strong commitment to diabetes is an essential part of building our business," said Gregg. "He has demonstrated success in delivering exceptional results in organizational development, sales volume, alliance development, market share and profit growth and Rick has dedicated much of his career to improving the lives of people suffering with diabetes. We are coming into a critical time for DexCom as we lead healthcare providers and patients to an understanding of the full potential of continuous glucose monitoring in diabetes as well as in other key settings."
Doubleday most recently worked as Director, Global Strategic Alliances for the Johnson & Johnson Family of Diabetes Companies. Doubleday joined Johnson & Johnson in May 1988 as a Retail Sales Representative with Advanced Care Products. He moved to LifeScan in 1996 as a National Account Manager. While at LifeScan, he also served as Area Manager, Consumer Sales, Field Sales Director, Consumer Sales, Field Sales Director, Professional Sales and Marketing Director, Health Care Professional Channel. In 2006, Doubleday moved to Animas as Director, Brand Marketing, responsible for promotion, positioning and messaging for new and existing products in the Animas portfolio. He then served as Director of Strategic Marketing and Alliances, responsible for developing and managing strategic alliances for Animas as well as helping to craft the long term portfolio strategy.
DexCom, headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
((Comments on this story may be sent to newsdesk@closeupmedia.com))
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
